ÂÜÀòÂÒÂ×

Todd Young is a seasoned healthcare professional with extensive experience in various roles within the biopharmaceutical industry. Current responsibilities at Rigel Pharmaceuticals Inc. focus on providing compliant scientific exchanges in hematology and oncology. Previously, as Vice President of Clinical Affairs at Faeth Therapeutics, Todd led clinical trial initiatives and managed budgets while establishing relationships with scientific leaders. In past positions, Todd drove clinical and scientific content at Proteus Digital Health, managed marketing for Erwinaze at Jazz Pharmaceuticals, and contributed significantly to gynecologic oncology initiatives at Genentech. Todd's earlier roles include leadership in investor relations at Angiotech and equity research at SG Cowen, complemented by a BA from Dartmouth College and an MD from New York Medical College.